Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EHU130431

Sigma-Aldrich

MISSION® esiRNA

targeting human S100A16

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CGCATCAGCTTCGATGAGTACTGGACCTTGATAGGCGGCATCACCGGCCCCATCGCCAAACTCATCCATGAGCAGGAGCAGCAGAGCAGCAGCTAGAGACCCCTTTGGCCACACCTTCCAGGCACTGGCCTGATGCCCCGCCCTGGTGCTCTCCCCAGGCTCCCTCCTCAGCCTCCTGCCCACCCAGGGCCCTTTACTCTCTTCTCCCTCCAGACCTTCCTCTGACCCTTGCTGAACTGGGGTCCCTTTGTGAGTGTCTCAGTCTAGAGGTACCTCCCTCCCTGGGGGGTCTCAGCTCCTGGAGTCGCAGGCCCTTGGGGCCCCTCTGTGAGATCTCAATGCTGTCTGGGGACCCTAAGAGTTTTCTCACCTGTTCAGTCTCATCTAACCTTCCAATGTCTGATGTTCCTGCCAAATTCCTG

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Huifang Lv et al.
Oncology research, 28(3), 225-236 (2019-12-05)
S100 binding protein A16 (S100A16) expression levels are closely associated with microRNA (miRNA) processing. Higher levels of S100A16 are reported during the progression of many cancers. Our study mainly explored the interaction between S100A16 and miR-6884-5p in gastric cancer (GC).
Dipak Sapkota et al.
BMC cancer, 15, 631-631 (2015-09-12)
Altered expression of S100A16 has been reported in human cancers, but its biological role in tumorigenesis is not fully understood. This study aimed to investigate the clinical significance and functional role of S100A16 in oral squamous cell carcinoma (OSCC) suppression.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service